Details for Patent: 12,097,206
✉ Email this page to a colleague
Which drugs does patent 12,097,206 protect, and when does it expire?
Patent 12,097,206 protects FINTEPLA and is included in one NDA.
Protection for FINTEPLA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-nine patent family members in sixteen countries.
Drugs Protected by US Patent 12,097,206
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | FINTEPLA | fenfluramine hydrochloride | SOLUTION;ORAL | 212102-001 | Jun 25, 2020 | RX | Yes | Yes | 12,097,206*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,097,206
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014261329 | ⤷ Subscribe | |||
| Australia | 2019203448 | ⤷ Subscribe | |||
| Australia | 2019203832 | ⤷ Subscribe | |||
| Australia | 2020267264 | ⤷ Subscribe | |||
| Brazil | 112015027282 | ⤷ Subscribe | |||
| Canada | 2909335 | ⤷ Subscribe | |||
| Cyprus | 1124298 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
